• New Insights Offered into CMT Type 4C from 5 Cases of Atypical Manifestations
  • Cure CMT4J Foundation Will Hold Fundraising Gala to Advance Clinical Trial
  • Researchers Uncover Molecular Consequences of CMT Type 2 Mutations
  • New Mutation Identified in Severe Form of Charcot-Marie-Tooth Disease
  • Study Links Eight Genes in Skin to Severity and Progression of Charcot-Marie-Tooth Disease
  • Despite Functional Limitations, Few CMT Patients Receive Physical and Occupational Therapy
  • Pharnext Amends Protocol of Phase 3 Trials of PXT3003 for CMT Type 1A
  • Researchers Identify New Mutation in Gene Linked to CMT Type 4H
  • Safety Board OKs Continuation of Phase 3 Trial of PXT3003 as a Charcot-Marie-Tooth Treatment
  • Pharnext to Hold Charcot-Marie-Tooth Symposium at Marseille Conference
  • Flex Pharma’s New CEO William McVicar to Continue Developing CMT Therapy Candidate FLX-787
  • CMT-Causing Gene Mutation Found in Study of Chinese Family